Not checked for notices yet.
Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab
Yuankai Shi, Hang Su, Yongping Song and 18 more
EBioMedicine · 2020
doi:10.1016/j.ebiom.2020.102731
Cited by papers we hold 1
- Sintilimab: A Promising Anti-Tumor PD-1 Antibody · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.